oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes SELECT Trial Oral Semaglutide and Cardiovascular Outcomes

In that environment, Lillys move reads like a retention tool to make the product easier to live with and reduce the little hassles that prompt patients to pause or quit

Keeping weight off isnt as simple as ignoring food cravings

Contact your GP if you experience these symptoms, as neurological damage from B12 deficiency can become irreversible if left untreated

If you need to shift your injection day during maintenance, a one-day advance is generally safe

These are the biological actors whose normal functions set the stage for understanding both what goes wrong in diabetes and how our medications are trying to fix it

Current evidence suggests Retatrutide may produce slightly more weight loss than Tirzepatide due to its triple-action mechanism